Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Blood (2007) 110 (11): 1975.

https://doi.org/10.1182/blood.V110.11.1975.1975

Published: 2007

Journal Articles

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Sahebi Firoozeh, MD, Jeffery R. Schriber, M.D., Ricardo Spielberger, M.D., Ji-Lian Cai, M.D., Neil Martin Kogut, M.D., Peter M. Falk, M.D., Pablo Miguel Parker, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Chatchada Karanes, M.D., Dajun Qian, PhD., Stephen J. Forman, M.D., George Somlo, M.D.

Blood (2007) 110 (11): 3030.

https://doi.org/10.1182/blood.V110.11.3030.3030

Published: 2007

Journal Articles

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Shirong Wang, MD, Auayporn P. Nademanee, MD, Dajun Qian, PhD, Andrew Dagis, PhD, Hyun-Soon Park, RN, Joy Fridey, MD, Eileen Patricia Smith, MD, David S. Snyder, MD, Ravi Bhatia, MD, Peter M. Falk, MD, Candace Kay, MT, Young Sun Kim, MD, Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Joseph Rosenthal, MD, George Somlo, MD, Anthony Selwyn Stein, MD, Shan Yuan, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 5434.

https://doi.org/10.1182/blood.V108.11.5434.5434

Published: 2006

Journal Articles

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Amrita Y. Krishnan, MD, Auayporn Nademanee, MD, Andrew Raubitschek, MD, Henry C. Fung, MD, Arturo Molina, MD, David Yamauchi, MD, Peter M. Falk, MD, Ricardo Spielberger, MD, Joycelynne Palmer, PhD, Ni Chun Tsai, MS, MPH, Jeffrey Schriber, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 3043.

https://doi.org/10.1182/blood.V108.11.3043.3043

Published: 2006

Journal Articles

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM).

Firoozeh Sahebi, MD, Neil M. Kogut, MD, Ricardo Spielberger, MD, Peter M. Falk, MD, Auayporn P. Nademanee, MD, Leslie Popplewell, MD, David G. Maloney, MD, Roberto Rodriguez, MD, Amrita Krishnan, MD, Ryotaro Nakamura, MD, Margaret R. O’Donnell, MD, Parker M. Pablo, MD, Eileen P. Smith, MD, Anthony S. Stein, MD, David S. Snyder, M.D, Jasmine M. Zain, MD, Dajun Qian, Ph.D, Stephen J. Forman, MD, George Somlo, MD

Blood (2005) 106 (11): 5427.

https://doi.org/10.1182/blood.V106.11.5427.5427

Published: 2005

Journal Articles

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

Amrita Krishnan, Arturo Molina, John Zaia, David Smith, Debbie Vasquez, Neil Kogut, Peter M. Falk, Joseph Rosenthal, Joseph Alvarnas, Stephen J. Forman

Blood (2005) 105 (2): 874–878.

https://doi.org/10.1182/blood-2004-04-1532

Published: 2005

Journal Articles

Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity

K Thalmeier, P Meissner, G Reisbach, M Falk, A Brechtel, P Dormer

Blood (1994) 83 (7): 1799–1807.

https://doi.org/10.1182/blood.V83.7.1799.1799

Published: 1994

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM).

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity

Email alerts

ASH Publications

American Society of Hematology

Update search

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

A Comparison of Beam and Yttrium 90 Ibritumomab Tiuxetan (Zevalin®) in Addition to Beam (Z-BEAM) in Older Patients Undergoing Autologous Stem Cell Transplant (ASCT) for B-Cell Lymphomas: Impact of Radioimmunotherapy on Transplant Outcomes.

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM).

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only